DTR’s news round-up 2019: the stories that defined the year
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
List view / Grid view
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
Gene editing using the CRISPR system has been established as the most powerful tool in the search for new drugs and is now being exploited for therapeutic purposes. Here, Pushpanathan Muthuirulan discusses the promises and wider opportunities of using CRISPR technology to open up the possibility of large-scale screening of…
Immunogens can be used to coax the immune system into producing broadly neutralising antibodies to fight a HIV infection, making a vaccine against the condition more likely, say researchers.
Researchers have developed a novel peptide with a prolonged half-life that has demonstrated success in rhesus monkeys and mice for inhibiting HIV infections.
Researchers have developed a vaccine for HIV that has shown success in rabbits, by neutralising a wide range of HIV strains using bnAbs.
A new discovery on how the immune system responds to malaria infection could lead to better treatments for hepatitis C, HIV and lupus.
New cell experiments show more effective genetic 'cuts' that could one day become the foundation of more effective gene therapies.
A study has demonstrated a novel vaccine design in mice which could be used to immunise patients against HIV.
Having worked in antibody research for over 20 years, Gary McLean has seen how the industry has progressed and understands the potential that antibodies have in the future of medicine. Nikki Withers hears how the focus has shifted from discovery to genetic sequence manipulation and how this can be applied…
An animal model to test HIV infection in infants could lead to biomarkers that predict viral rebound after ART interruption.
Researchers have developed a new HIV vaccine which has shown success in monkeys in pre-clinical trial studies.
A promising vaccine that clears an HIV-like virus from monkeys is closer to clinical trial human testing.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
A study of almost half a million people links a mutation that protects against HIV infection to an earlier death.
Computational modelling has been used to design proteins that mimic the conserved protein surface of different strains of HIV for use in vaccines...